AMENDMENT AGREEMENT NO. 2Agreement • August 6th, 2015 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
This AMENDMENT AGREEMENT NO. 2 (this “Agreement”) effective as of ____, 2015 (the “Effective Time”), between MabVax Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), and the investor signatory hereto (the “Purchaser”), hereby consents to certain waivers and modifications to the Registration Rights Agreement, as amended by that certain Amendment Agreement dated as of June 9, 2015 (the “Original Amendment Agreement” and such Registration Rights Agreement as amended by the Original Amendment Agreement, the “Registration Rights Agreement”) executed in connection with the purchase by the Purchaser of Units (as defined below) of the Company’s securities pursuant to that certain Subscription Agreement governing the sale of the Units described below (the “Subscription Agreement”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Registration Rights Agreement or the Subscription Agreement. Except as specifically agreed to
